Company intelligence / Profile preview

PlasmidFactory

Bielefeld, North Rhine-Westphalia, Germanyplasmidfactory.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

PlasmidFactory provides high-purity plasmids and minicircles as starting materials for advanced therapies. Its proprietary minicircle technology enables nonviral engineering of CAR-T cells currently undergoing clinical trials with reported initial successes. The company’s products are widely used in mRNA vaccine manufacturing and gene/cell therapy R&D worldwide.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: plasmid DNA (pDNA)minicircle DNAcustom DNA constructs for gene and cell therapymRNA productionAAV productionCAR-T cell development
Industry: Contract Manufacturing Organization

Partnerships

ARCHIMED (private equity partner/investor)Bielefeld University (academic collaboration)MDCell (collaboration on customized MIDGE® DNA)

Beyond the preview

Go deeper on PlasmidFactory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlasmidFactory.

Explore the full profile